152 related articles for article (PubMed ID: 26998164)
21. Interaction of CJY, an isoflavone, with ATPase of P-glycoprotein in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Cen J; Liu L; He L; Ji BS
Drug Res (Stuttg); 2013 Aug; 63(8):429-34. PubMed ID: 23720244
[TBL] [Abstract][Full Text] [Related]
22. [The relationship between multi-drug resistance and proportion of leukemia stem cells and expression of drug transporters in drug-resistant leukemia K562/ADM cells].
Yi J; Chen J; Sun J; Wei HL
Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(25):1741-4. PubMed ID: 19862976
[TBL] [Abstract][Full Text] [Related]
23. Combination of Protoporphyrin IX-mediated Sonodynamic Treatment with Doxorubicin Synergistically Induced Apoptotic Cell Death of a Multidrug-Resistant Leukemia K562/DOX Cell Line.
Wang X; Jia Y; Su X; Wang P; Zhang K; Feng X; Liu Q
Ultrasound Med Biol; 2015 Oct; 41(10):2731-9. PubMed ID: 26166458
[TBL] [Abstract][Full Text] [Related]
24. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
[TBL] [Abstract][Full Text] [Related]
25. Vielanin P enhances the cytotoxicity of doxorubicin via the inhibition of PI3K/Nrf2-stimulated MRP1 expression in MCF-7 and K562 DOX-resistant cell lines.
Gao HL; Xia YZ; Zhang YL; Yang L; Kong LY
Phytomedicine; 2019 May; 58():152885. PubMed ID: 31009836
[TBL] [Abstract][Full Text] [Related]
26. Reversal of P-glycoprotein-mediated multidrug resistance by diallyl sulfide in K562 leukemic cells and in mouse liver.
Arora A; Seth K; Shukla Y
Carcinogenesis; 2004 Jun; 25(6):941-9. PubMed ID: 14729595
[TBL] [Abstract][Full Text] [Related]
27. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol.
Arora A; Seth K; Kalra N; Shukla Y
Toxicol Appl Pharmacol; 2005 Feb; 202(3):237-43. PubMed ID: 15667829
[TBL] [Abstract][Full Text] [Related]
28. [Induction of anti-leukemic immunity of dendritic cells derived from multidrug resistant leukemia K562/A02 cells with high expression of P-glycoprotein and sensitive K562 cells].
Zhang YM; Zhang LS; Zhang YF; Yi LC; Chai Y; Song FX; Zeng PY; Liu Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1018-22. PubMed ID: 16403271
[TBL] [Abstract][Full Text] [Related]
29. Medicarpin and millepurpan, two flavonoids isolated from Medicago sativa, induce apoptosis and overcome multidrug resistance in leukemia P388 cells.
Gatouillat G; Magid AA; Bertin E; El btaouri H; Morjani H; Lavaud C; Madoulet C
Phytomedicine; 2015 Dec; 22(13):1186-94. PubMed ID: 26598918
[TBL] [Abstract][Full Text] [Related]
30. [Reversal effect of haloperidol on doxorubicin resistance and chloride channel inhibition in erythroleukemic cell K562/Dox].
Zhou JH; Wu DZ
Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):81-5. PubMed ID: 15946544
[TBL] [Abstract][Full Text] [Related]
31. Indomethacin overcomes doxorubicin resistance with inhibiting multi-drug resistance protein 1 (MRP1).
Matsunaga S; Asano T; Tsutsuda-Asano A; Fukunaga Y
Cancer Chemother Pharmacol; 2006 Sep; 58(3):348-53. PubMed ID: 16331495
[TBL] [Abstract][Full Text] [Related]
32. Sensitivity of K562 human chronic myelogenous leukemia blast cells transfected with a human multidrug resistance cDNA to cytotoxic drugs and differentiating agents.
Hait WN; Choudhury S; Srimatkandada S; Murren JR
J Clin Invest; 1993 May; 91(5):2207-15. PubMed ID: 8098047
[TBL] [Abstract][Full Text] [Related]
33. The transmembrane glycoprotein CD38 is a catalytically active transporter responsible for generation and influx of the second messenger cyclic ADP-ribose across membranes.
Franco L; Guida L; Bruzzone S; Zocchi E; Usai C; De Flora A
FASEB J; 1998 Nov; 12(14):1507-20. PubMed ID: 9806760
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanism study of chemosensitization of doxorubicin-resistant human myelogenous leukemia cells induced by a composite polymer micelle.
Han M; Diao YY; Jiang HL; Ying XY; Chen DW; Liang WQ; Gao JQ
Int J Pharm; 2011 Nov; 420(2):404-11. PubMed ID: 21945184
[TBL] [Abstract][Full Text] [Related]
35. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
[TBL] [Abstract][Full Text] [Related]
36. Sodium azulene sulfonate reverses multidrug resistance in K562/A02 cells.
Wang Z; Zhou N; Zhao J; Zhang X
Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):105-110. PubMed ID: 31880526
[TBL] [Abstract][Full Text] [Related]
37. Does P-glycoprotein play a pivotal role in the drug resistance of an MDR variant, K562/Dox?
Hu X; Yang H; Pan QR; Zheng S
Chemotherapy; 1995; 41(4):296-305. PubMed ID: 7555211
[TBL] [Abstract][Full Text] [Related]
38. Solanine reverses multidrug resistance in human myelogenous leukemia K562/ADM cells by downregulating MRP1 expression.
Yi YJ; Jia XH; Zhu C; Wang JY; Chen JR; Wang H; Li YJ
Oncol Lett; 2018 Jun; 15(6):10070-10076. PubMed ID: 29928376
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers.
Chen YL; Yang TY; Chen KC; Wu CL; Hsu SL; Hsueh CM
Cell Oncol (Dordr); 2016 Oct; 39(5):411-433. PubMed ID: 27306525
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic effect of the protein-doxorubicin conjugates on the multidrug-resistant human myelogenous leukemia cell line, K562, in vitro.
Hatano T; Ohkawa K; Matsuda M
Tumour Biol; 1993; 14(5):288-94. PubMed ID: 8235308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
